Third quarter sales grew 7.8% year-over-year, driven by strong pricing and improving volumes, with adjusted operating margin reaching 10.6%. Vending and implant solutions saw double-digit growth, and cost structure improvements led to higher profitability. Outlook for Q4 anticipates continued sales and margin strength.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.